MANIEZZI CLAUDIA
Pubblicazioni
Maniezzi, C., Eskandr, M., Florindi, C., Ferrandi, M., Barassi, P., Sacco, E., et al. (2024). Early consequences of the phospholamban mutation PLN-R14del+/- in a transgenic mouse model [Altro] [10.1101/2023.04.05.535536]. Dettaglio
Maniezzi, C., Bastaroli, F., Dusi, V., Florindi, C., Eskandr, M., Anzaldi, I., et al. (2024). Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 2. VASCULAR PHARMACOLOGY, 155(June 2024) [10.1016/j.vph.2024.107329]. Dettaglio
Maniezzi, C., Eskandr, M., Florindi, C., Ferrandi, M., Barassi, P., Sacco, E., et al. (2024). Early consequences of the phospholamban mutation PLN-R14del+/− in a transgenic mouse model. ACTA PHYSIOLOGICA, 240(3 (March 2024)) [10.1111/apha.14082]. Dettaglio
Lodola, F., Maniezzi, C., Eskandr, M., Florindi, C., de Boer, R., Silljé, H., et al. (2023). Exploring the pathophysiological role of the PLN-R14del mutation in a novel heterozygous mouse model of dilated cardiomyopathy. Intervento presentato a: Biophysical Society, San Diego, Ca, Usa [10.1016/j.bpj.2022.11.2096]. Dettaglio
Vurro, V., Federici, B., Ronchi, C., Florindi, C., Sesti, V., Crasto, S., et al. (2023). Optical modulation of excitation-contraction coupling in human-induced pluripotent stem cell-derived cardiomyocytes. ISCIENCE, 26(3) [10.1016/j.isci.2023.106121]. Dettaglio